潜水简介：
- Tate & Lyle is spending $237 million to购买量子高科技（广东）生物学，来自ChemPartner Pharmatech的中国益生元饮食纤维业务。
- 这些成分提供商表示，此次收购与其成为以增长为中心的食品和饮料解决方案公司的目标保持一致，同时增强了其在迅速扩大的全球饮食纤维市场中的参与者的地位。
- 益生元饮食纤维通过帮助良好的细菌在个体的肠道中生长，在支持消化健康方面起着重要作用。这些成分越来越受到食品和饮料制造商的追捧，以及消费者为改善自己的身心健康而寻求更好的产品。
Dive Insight:
As COVID-19 has shown, shoppers care about what goes into their bodies more than ever and they are placing a greater priority on products that contain functional attributes such as prebiotics.
一些品牌甚至使益生元纤维成为其销售商品的焦点。百事可乐的凯维塔（Kevita）具有益生元镜头it claims are the first of their kind on the market. Better-for-you soda brandsOlipopandPoppitout the use of prebiotics in their drinks. Functional food brand Uplift sells bars, powders, puffs and other products loaded with the ingredient.MondelēzInternational占据了少数股份在2019年的公司中，Clif Bar的Luna品牌也使用了研究，并指出了其对肠道的积极影响。
在许多水果和蔬菜中发现的益生元是not actually digested by the body但是，它们通过消化系统，在那里它们成为细菌和其他微生物的食物。估计在消化系统中发现了70％至80％的免疫细胞，据考证，那些肠道通常是最健康的肠道，通常会接受纤维含量高的植物食品饮食。
As people look to increase their intake of functional ingredients while curtailing consumption of things such as sugar, companies like Tate & Lyle are shrewdly bulking up their portfolios to reflect this shift. When food companies look to add a new product that incorporates plant-based ingredients, clean label or functional additives, those businesses that supply them need to dabble in many of these areas at the same time and have a diverse portfolio.
The acquisition is "very much in line with our purpose to support healthy living by improving gut health, and driving sugar and calorie reduction andfibrefortification for consumers across the world,” Nick Hampton, Tate & Lyle's CEO, said in a written statement.
预计该交易将在今年第二季度完成。
收购是泰特（Tate＆Lyle）考虑的分为两个实体：食品和饮料解决方案和主要产品。食品和饮料解决方案是生产Tate＆Lyle的新成分创新的部门，包括减少糖和卡路里，增加纤维和质地以及稳定。
在潜在的分裂之前，Tate＆Lyle一直在通过交易和收购。
在2020年，它购买了甜菊生产者甜绿色领域还有85％的股份总部位于泰国的木薯制造商Chaodee改良淀粉。这些交易为Tate＆Lyle的成分投资组合带来了新的选择，无论是成分和功能以及来源而言。量子采集进一步增加了该部门的重量，这可能使其成为更受欢迎的合作伙伴，如果Tate＆Lyle决定通过分离前进。
